Latin America OTC Drugs Industry value worth USD 26.73 Bn by 2021
According to the report Latin America OTC Drugs Industry, published by Market Data Forecast,
The Industry in Latin America region has been estimated at USD 18.44 billion in
2016 and is projected to reach USD 26.73 billion by 2021, at a CAGR of 7.71%
during the forecast period from 2016 to 2021. Brazil, Mexico and Argentina are
the leading contributors to the Latin America OTC drugs Industry
Over-the-counter (OTC) drugs are medicines
sold directly to a consumer without a prescription from a healthcare professional,
as compared to prescription drugs, which may be sold only to consumers
possessing a valid prescription. Some drugs may be legally classified as
over-the-counter (i.e. no prescription is required), but may only be dispensed
by a pharmacist after an assessment of the patient's needs or the provision of
patient education.
Browse Industry data tables
and in-depth TOC of the Latin America OTC Drugs Industry to 2021 @ http://www.marketdataforecast.com/market-reports/latin-america-over-the-counter-drugs-market-513/
Increasing adoption of western lifestyles and
growing prosperities is leading to increase in Industry size and OTC demand.
Promotion and Industrying initiatives will be a key trend for Industry growth
in the forecast period for this region. The growing healthcare costs and an
increase in the older population demand the need for better accessibility and
affordability of healthcare services. Self-medication with non-prescription
drugs play an important role in this and help in improving the accessibility
and cost-benefits of healthcare services.
GlaxoSmithKline, Johnson and Johnson,
Novartis, Bayer, Pfizer, Sanofi and Takeda are the leading companies that
contribute to Latin America Industry.
Free sample of the report is
available @ http://www.marketdataforecast.com/market-reports/latin-america-over-the-counter-drugs-market-513/request-sample
Key
Points from Table of Contents
Overview
·
Executive
Summary
·
Key
Inferences
·
New
Developments
Drivers, Restraints, Opportunities, and
Challenges Analysis
(DROC)
Latin America OTC Drugs Industry: Segmentation
·
Product
Type
o
Analgesics
o
Cough, Cold and Flu
Products
o
Vitamins and Minerals
o
Dermatological Products
o
Gastrointestinal Products
o
Ophthalmic
Products
o
Sleep Aid
Products
o
Weight Loss/Diet
Products
o
Others
·
By Formulation
Type
o
Tablets
o
Liquids
o
Ointments
o
Sprays
·
Distribution
Channels
o
Pharmacies
o
SuperIndustrys/HyperIndustrys
o
Convenience
stores
o
Others (Online Drug Stores)
Geographical Analysis
Brazil
Mexico
Argentina
Rest of Latin America
Strategic
Analysis
·
PESTLE
analysis
·
Porter’s Five
analysis
Industry Leaders'
Analysis
Competitive
Landscape
Avail discount @ http://www.marketdataforecast.com/market-reports/latin-america-over-the-counter-drugs-market-513/request-discount
Market Data Forecast is a firm working in the
area of market research and business intelligence. With rich experience in
research across various business domains, we cater to the needs of both
individual and corporate clients. Our analyst team comprises expert
professionals in market research, who with their collective knowledge and sksillset
dedicatedly serve clients from various industries and regions.
Contact:
Abhishek Shukla
Sales Manager (International
Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
View latest Press Releases
of MDF @ http://www.marketdataforecast.com/press-releases
Comments
Post a Comment